Folic acid, B vitamins dont reduce cardiovascular risk in womenMay 7th, 2008 - 12:33 pm ICT by admin
Washington, May 7 (ANI): A new study has found that long-term supplementation of folic acid and vitamin B supplements do not protect women against heart disease and stroke.
Randomised, controlled trials by Christine M. Albert, M.D., M.P.H., of Brigham and Womens Hospital and Harvard Medical School, Boston, and colleagues, showed that women at high-risk of cardiovascular disease who took a daily supplement of folic acid and vitamin B6 and B12 for seven years did not have an overall reduced rate of cardiovascular events, despite a significant lowering of homocysteine levels.
Homocysteine [an amino acid produced by the body] levels have been directly associated with cardiovascular risk in observational studies; and daily supplementation with folic acid, vitamin B6, vitamin B12, or a combination have been shown to reduce homocysteine levels to varying degrees in intervention studies, the authors said.
Observational data suggest cardiovascular benefits from B-vitamin supplementation may be greater among women, yet women have been underrepresented in published randomized trials.
Given the paucity of data on women and the known influences of estrogen on homocysteine levels, adequately powered randomized trials of homocysteine lowering in women are still needed, the authors said.
The researchers tested whether a combination of folic acid, vitamin B6 and vitamin B12 would reduce total cardiovascular events among women at high risk for the development of cardiovascular disease (CVD) over 7 years of follow-up.
Within an ongoing randomized trial of antioxidant vitamins, 5,442 women who were U.S. health professionals age 42 years or older, with either a history of CVD or three or more coronary risk factors, were enrolled in a randomized trial to receive a combination pill containing folic acid (2.5 mg), vitamin B6 (50 mg), and vitamin B12 (1 mg) or a matching placebo.
During the 7.3 years of follow-up, 796 participants (14.6 percent) experienced a confirmed CVD event included in the primary end point (heart attack, stroke, coronary revascularization, or CVD death), with some individuals experiencing more than one event.
There was no difference in the cumulative incidence of the primary combined end point in the active vs. placebo treatment groups at any time during study follow-up. A total of 406 women (14.9 percent) in the active treatment group and 390 (14.3 percent) in the placebo group experienced at least one cardiovascular event included in the primary end point.
When analyzed separately, there were no significant differences for each of the components of the primary outcome including heart attack, stroke, and CVD death, between the active treatment and placebo groups. Also, the risk of death from any cause was similar between the active and placebo treatment groups.
The researchers also found that the average plasma homocysteine level was 18.5 percent lower in the active group than that observed in the placebo group.
Our results are consistent with prior randomized trials performed primarily among men with established vascular disease and do not support the use of folic acid and B vitamin supplements as preventive interventions for CVD in these high-risk fortified populations, the authors said.
The study appears in the May 7 issue of JAMA. (ANI)
- Meta-analysis shows folic acid supplements not beneficial for heart - Oct 12, 2010
- B vitamin therapy leads to kidney function decline in kidney disease patients - Apr 28, 2010
- Heart patients receiving folic acid treatment 'at increased cancer, death risk' - Nov 18, 2009
- Diet high in B-vitamins 'lowers heart risk' - Apr 16, 2010
- Diet high in B-vitamins lowers heart risk - Apr 19, 2010
- Vitamin B pills don't cut down risk of heart disease - Oct 07, 2009
- Large doses of B-complex vitamins may help slow progression of dementia - Oct 26, 2010
- Folic acid and other B vitamins do not prevent cancer - Nov 05, 2008
- Why folic acid won't prevent a heart attack - Feb 03, 2011
- Take Vitamin B to lower work stress - Nov 10, 2011
- Vitamins E and C 'have little effect on age-related cataract' - Nov 09, 2010
- Vitamin B12 may protect against Alzheimer's disease - Oct 19, 2010
- High heart attack risks in vegans can be cut by omega-3s and B12 - Feb 03, 2011
- Calcium supplements cause heart problems in women? - Apr 24, 2011
- B-Vitamins ease depression among stroke victims - Oct 29, 2010
Tags: antioxidant vitamins, b vitamin, b vitamins, brigham and womens, brigham and womens hospital, cardiovascular benefits, cardiovascular events, cardiovascular risk, combination pill, coronary risk factors, harvard medical school, harvard medical school boston, homocysteine levels, intervention studies, mg vitamin b6, observational data, observational studies, risk of cardiovascular disease, vitamin b12, vitamin supplementation